Regulation of Generic Drugs in Japan: the Current Situation and Future Prospects

  title={Regulation of Generic Drugs in Japan: the Current Situation and Future Prospects},
  author={Ryosuke Kuribayashi and Maki Matsuhama and Kenichi Mikami},
  journal={The AAPS Journal},
Generic drugs are interchangeable with original proprietary drugs, as they have the same active pharmaceutical ingredients, dosage forms, strength, quality, indications, effects, directions, and dosage. The cost of generic drugs is lower than original drugs, because the developmental cost is lower. The expansion of medical expenses is an important issue in many countries, including Japan, the USA, and Europe, and promotion of generic drugs has been demanded to solve this issue in Japan. Generic… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-7 of 7 extracted citations


Publications referenced by this paper.
Showing 1-9 of 9 references

for industry, ANDA submissions—amendments and easily correctable deficiencies under GDUFA

  • FDA. Guidanc
  • 2014. . http://…
  • 2015

of the use of generic drugs

  • MHLW. Promotio
  • 2012. http://…
  • 2015

Mid-term plan of the Pharmaceuticals and Medical Devices Agency (PMDA)

  • files/000198796.pdf…
  • 2014

United States Census Bureau. An aging nation: the older population in the United States

  • J. M. Ortman, Velkoff, V. A. Howard Hogan
  • p251140.pdf…
  • 2014

Healthcare Iinformatics

  • IMS Institute Fo
  • Avoidable costs in U.S. healthcare.
  • 2013

Recent developments in global pricing

  • Simon-Kucher, PartnersHealthcare Insights
  • 2013

guidance on fluticasone propionate; salmeterol xinafoate

  • FDA. Draf
  • 2013. downloads/Drugs…
  • 1316

Similar Papers

Loading similar papers…